Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database
BÉGAUD, Bernard
Pharmacoepidemiologie et évaluation de l'impact des produits de santé sur les populations
< Leer menos
Pharmacoepidemiologie et évaluation de l'impact des produits de santé sur les populations
Idioma
en
Article de revue
Este ítem está publicado en
Drug Safety. 2017-11, vol. 40, n° 11, p. 1099-1107
Springer Verlag
Resumen en inglés
The objective of this study was to analyse the changes in the reporting of adverse events (AEs) for therapeutic alternatives after the withdrawal of three medicines (dextropropoxyphene, pioglitazone and tetrazepam) from ...Leer más >
The objective of this study was to analyse the changes in the reporting of adverse events (AEs) for therapeutic alternatives after the withdrawal of three medicines (dextropropoxyphene, pioglitazone and tetrazepam) from the market for safety reasons.< Leer menos
Palabras clave en inglés
medicine
therapeutic alternatives
politics
Proyecto ANR
Initiative d'excellence de l'Université de Bordeaux - ANR-10-IDEX-0003
Orígen
Importado de Hal